HC Wainwright Reaffirms Buy Rating for OPKO Health (NASDAQ:OPK)
HC Wainwright restated their buy rating on shares of OPKO Health (NASDAQ:OPK – Free Report) in a report released on Wednesday, Benzinga reports. The firm currently has a $3.00 target price on the biotechnology company’s stock. A number of other analysts have also issued reports on the company. Barrington Research reissued an outperform rating and […]
More Stories
AT&T (NYSE:T) Stock Rating Upgraded by Royal Bank of Canada
Royal Bank of Canada upgraded shares of AT&T (NYSE:T – Free Report) from a sector perform rating to an outperform...
Truist Financial Lowers UnitedHealth Group (NYSE:UNH) Price Target to $610.00
UnitedHealth Group (NYSE:UNH – Free Report) had its price objective lowered by Truist Financial from $625.00 to $610.00 in a...
Aptiv (NYSE:APTV) Now Covered by Analysts at StockNews.com
StockNews.com initiated coverage on shares of Aptiv (NYSE:APTV – Free Report) in a research report report published on Monday. The...
BMO Capital Markets Upgrades Capri (NYSE:CPRI) to “Outperform”
BMO Capital Markets upgraded shares of Capri (NYSE:CPRI – Free Report) from a market perform rating to an outperform rating...
Insider Selling: B.P. Marsh & Partners PLC (LON:BPM) Insider Sells £138,937.50 in Stock
B.P. Marsh & Partners PLC (LON:BPM – Get Free Report) insider Francesca Chappell sold 18,750 shares of the stock in...
Bragg Gaming Group (NASDAQ:BRAG) Given New $5.00 Price Target at JMP Securities
Bragg Gaming Group (NASDAQ:BRAG – Free Report) had its price target lowered by JMP Securities from $6.00 to $5.00 in...